Small caps round-up: Cyprotex, Noble Investments, Accumuli
Cyprotex rose over three per cent after it said it had signed a licensing agreement with Sigma Life Science. Cyprotex will add Sigma's CompoZr Zinc Finger Nuclease technology to its screening services in an agreement that marks the first non-exclusive licence granted by Sigma for the technology.
Cyprotex rose over three per cent after it said it had signed a licensing agreement with Sigma Life Science. Cyprotex will add Sigma's CompoZr Zinc Finger Nuclease technology to its screening services in an agreement that marks the first non-exclusive licence granted by Sigma for the technology.
Noble Investments, the international rare coin and stamp dealer and auctioneer, said its auction business, Baldwin's, was owed £2.2m in commission after "a significant Qatari collector" had failed to pay the bill its services. The collector is yet to receive the coins purchased but the news pushed shares down 5.7%. The firm said it was taking legal advice on the matter. Noble also said it was on track to meet full year expectations.
Accumuli, a provider of IT security services, said trading in the six months to the end of September was in line with management expectations despite the wider adverse macro economic climate. The group said it continued to achieve strong cash generation. After acquisition costs and the initial £0.9m payout for EdgeSeven, which it bought in June, the firm said it had a cash pile of £1.5m.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
MM
Sign up for MoneyWeek's newsletters
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
MoneyWeek is written by a team of experienced and award-winning journalists, plus expert columnists. As well as daily digital news and features, MoneyWeek also publishes a weekly magazine, covering investing and personal finance. From share tips, pensions, gold to practical investment tips - we provide a round-up to help you make money and keep it.
-
Trouble brews in B&M as bargain shops take a hit
Opinion Once a stock market darling, B&M's share price has slumped. What has gone wrong for bargain shops?
-
US and China reach a ceasefire in their trade war after talks in London
The US and China's trading relationship – the most important one in the global economy – is back on track. Will the truce last?